Alexander Artyukhov

Dr. Alexander Artyukhov

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
MDMaria Drozdova
Maria Drozdova
DZDaria S. Zaytseva-Zotova
Daria S. Zaytseva-Zotova
RARoman Akasov
Roman Akasov
AGAnna Golunova
Anna Golunova
Alexander ArtyukhovAlexander Artyukhov
Alexander Artyukhov
EMElena Markvicheva
Elena Markvicheva

25 June 2010 in Journal of Polymer Research
Verified
Journal Article
Closed access
PDF file
Alexander ArtyukhovAlexander Artyukhov
Alexander Artyukhov
MSMikhail I. Shtilman
Mikhail I. Shtilman
Andrey KuskovAndrey Kuskov
Andrey Kuskov
AFAnna P. Fomina
Anna P. Fomina
DLDenis E. Lisovyy
Denis E. Lisovyy
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis

23 February 2010 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
Andrey KuskovAndrey Kuskov
Andrey Kuskov
AVAnna A. Voskresenskaya
Anna A. Voskresenskaya
AGAnastasiya V. Goryachaya
Anastasiya V. Goryachaya
Alexander ArtyukhovAlexander Artyukhov
Alexander Artyukhov
MSMikhail I. Shtilman
Mikhail I. Shtilman
Aristidis TsatsakisAristidis Tsatsakis
Aristidis Tsatsakis

13 October 2022 in Materials
Verified
Journal Article
Open access
PDF file
Alexander ArtyukhovAlexander Artyukhov
Alexander Artyukhov
ANAnna M. Nechaeva
Anna M. Nechaeva
MSMikhail I. Shtilman
Mikhail I. Shtilman
Evgeniy ChistyakovEvgeniy Chistyakov
Evgeniy Chistyakov
ASAlina Yu. Svistunova
Alina Yu. Svistunova
YMYaroslav Mezhuev
Yaroslav Mezhuev
Application of nanocarriers for drug delivery brings numerous advantages, allowing both minimization of side effects common in systemic drug delivery and improvement in targeting, which has made it the focal point of nanoscience for a number of years. While most of the studies are focused on encapsulation of hydrophobic drugs, delivery of hydrophilic compounds is typically performed via covalent attachment, which often requires chemical modification of the drug and limits the release kinetics. In this paper, we report synthesis of biphilic copolymers of various compositions capable of self-assembly in water with the formation of nanoparticles and suitable for ionic binding of the common anticancer drug doxorubicin. The copolymers are synthesized by radical copolymerization of N-vinyl-2-pyrrolidone and acrylic acid using n-octadecyl-mercaptan as a chain transfer agent. With an increase of the carboxyl group’s share in the chain, the role of the electrostatic stabilization factor of the nanoparticles increased as well as the ability of doxorubicin as an ion binder. A mathematical description of the kinetics of doxorubicin binding and release is given and thermodynamic functions for the equilibrium ionic binding of doxorubicin are calculated.

23 April 2022 in Polymers
Verified
Journal Article
Open access
PDF file
ANAnna M. Nechaeva
Anna M. Nechaeva
Alexander ArtyukhovAlexander Artyukhov
Alexander Artyukhov
ALAnna Luss
Anna Luss
MSMikhail Shtilman
Mikhail Shtilman
IGInessa A. Gritskova
Inessa A. Gritskova
Yaroslav MezhuevYaroslav Mezhuev
Yaroslav Mezhuev
Co-delivery of chemotherapeutics in cancer treatment has been proven essential for overcoming multidrug resistance and improving the outcome of therapy. We report the synthesis of amphiphilic copolymers of N-vinyl-2-pyrrolidone and allyl glycidyl ether of various compositions and demonstrate that they can form nanoaggregates capable of simultaneous covalent immobilization of doxorubicin by the epoxy groups in the shell and hydrophobic-driven incorporation of paclitaxel into the core of nanoparticles. The structure of the obtained copolymers was characterized by 13C NMR, IR, and MALDI spectroscopy, as well as adsorption at the water/toluene interface. A linear increase in the number-average molecular weight of amphiphilic copolymers and a decrease in the number-average diameter of macromolecular aggregates with an increase in the ratio N-vinyl-2-pyrrolidone/allyl glycidyl ether were observed. The assembled nanocarriers were characterized by DLS. The reported novel nanocarriers can be of interest for delivery and co-delivery of a wide range of pharmacological preparations and combined therapy for cancer and other deceases.

30 June 2021 in Polymers
Verified
Journal Article
Open access
PDF file
Yaroslav MezhuevYaroslav Mezhuev
Yaroslav Mezhuev
IVIgor Y. Vorobev
Igor Y. Vorobev
IPIvan V. Plyushchii
Ivan V. Plyushchii
EKEfrem Georgievich Krivoborodov
Efrem Georgievich Krivoborodov
Alexander ArtyukhovAlexander Artyukhov
Alexander Artyukhov
YKYuri V. Korshak
Yuri V. Korshak
The kinetic regularities of the initial stage of chemical oxidative polymerization of methylene blue under the action of ammonium peroxodisulfate in an aqueous medium have been established by the method of potentiometry. It was shown that the methylene blue polymerization mechanism includes the stages of chain initiation and growth. It was found that the rate of the initial stage of the reaction obeys the kinetic equation of the first order with the activation energy 49 kJ · mol−1. Based on the proposed mechanism of oxidative polymerization of methylene blue and the data of MALDI, EPR, and IR spectroscopy methods, the structure of the polymethylene blue chain is proposed. It has been shown that polymethylene blue has a metallic luster, and its electrical conductivity is probably the result of conjugation over extended chain sections and the formation of charge transfer complexes. It was found that polymethylene blue is resistant to heating up to a temperature of 440 K and then enters into exothermic transformations without significant weight loss. When the temperature rises above 480 K, polymethylene blue is subject to endothermic degradation and retains 75% of its mass up to 1000 K.